A glycan-based approach to therapeutic angiogenesis

Area of Science:

• Biochemistry
• Cell Biology
• Vascular Biology

Background:

• Angiogenesis is vital for healing and regeneration but current growth factor strategies are limited.
• Existing methods to enhance pro-angiogenic factors like VEGF and FGF2 show limited success.
• Therapeutic angiogenesis aims to treat diseases like limb ischemia and chronic wounds.

Purpose of the Study:

• To investigate the potential of novel small molecules, click-xylosides, in promoting angiogenesis.
• To evaluate the efficacy of xylosides in promoting blood vessel formation and network stability.
• To elucidate the underlying molecular mechanisms of xyloside-mediated angiogenesis.

Main Methods:

• In vitro matrigel tube formation assay.
• Ex ovo chick chorioallantoic membrane assay.
• Analysis of glycosaminoglycans (GAGs) and ERK1/2 signaling pathway.

Main Results:

• Click-xylosides demonstrated significant pro-angiogenic activity in both assays.
• Xyloside treatment enhanced endothelial cell network connectivity and survivability.
• The pro-angiogenic effects were mediated by secreted xyloside-primed GAGs acting via ERK1/2 signaling.

Conclusions:

• Click-xylosides represent a novel therapeutic strategy for promoting angiogenesis.
• The glycan approach using xylosides offers potential for treating angiogenesis-related disorders.
• Modulating GAGs in the extracellular matrix is a promising avenue for therapeutic angiogenesis.